Short term speculations with shorter's in mind for TFC, page-5

I think you are right jinx
But the biological valuations should be more heavily scrutinized as they have not traditionally been valued independently, but rather valued by the people who run the company. An independent valuation can only provide one of three things. A one in three chance that an independent valuation provides an unfavorable outcome is a risky bet indeed, especially with such a volatile stock as this.